CN102414198B - 3-{[(2r)-1-甲基吡咯烷-2-基]甲基}-5-[2-(苯基磺酰基)乙基]-1h-吲哚的合成 - Google Patents

3-{[(2r)-1-甲基吡咯烷-2-基]甲基}-5-[2-(苯基磺酰基)乙基]-1h-吲哚的合成 Download PDF

Info

Publication number
CN102414198B
CN102414198B CN200980158923.7A CN200980158923A CN102414198B CN 102414198 B CN102414198 B CN 102414198B CN 200980158923 A CN200980158923 A CN 200980158923A CN 102414198 B CN102414198 B CN 102414198B
Authority
CN
China
Prior art keywords
salt
eletriptan
formula
solvent
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200980158923.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN102414198A (zh
Inventor
希洛·塞拉菲尼
安德里·卡斯特林
克劳迪奥·达尔桑托
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fabbrica Italiana Sintetici SpA (FIS)
Original Assignee
Fabbrica Italiana Sintetici SpA (FIS)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabbrica Italiana Sintetici SpA (FIS) filed Critical Fabbrica Italiana Sintetici SpA (FIS)
Publication of CN102414198A publication Critical patent/CN102414198A/zh
Application granted granted Critical
Publication of CN102414198B publication Critical patent/CN102414198B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
CN200980158923.7A 2009-04-22 2009-11-09 3-{[(2r)-1-甲基吡咯烷-2-基]甲基}-5-[2-(苯基磺酰基)乙基]-1h-吲哚的合成 Active CN102414198B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2009A000678A IT1393700B1 (it) 2009-04-22 2009-04-22 Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo
ITMI2009A000678 2009-04-22
PCT/EP2009/064850 WO2010121673A1 (en) 2009-04-22 2009-11-09 Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole

Publications (2)

Publication Number Publication Date
CN102414198A CN102414198A (zh) 2012-04-11
CN102414198B true CN102414198B (zh) 2014-11-12

Family

ID=41314669

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980158923.7A Active CN102414198B (zh) 2009-04-22 2009-11-09 3-{[(2r)-1-甲基吡咯烷-2-基]甲基}-5-[2-(苯基磺酰基)乙基]-1h-吲哚的合成

Country Status (8)

Country Link
US (1) US8426612B2 (https=)
EP (1) EP2421853B1 (https=)
JP (1) JP5663559B2 (https=)
CN (1) CN102414198B (https=)
CA (1) CA2756234C (https=)
ES (1) ES2432066T3 (https=)
IT (1) IT1393700B1 (https=)
WO (1) WO2010121673A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102786514B (zh) * 2012-07-26 2014-01-29 武汉人福医药集团股份有限公司 依来曲普坦的制备方法
CN104341397A (zh) * 2013-07-31 2015-02-11 上海威智医药科技有限公司 具晶型的依来曲普坦自由碱及其制法和应用
CN105175397B (zh) * 2015-09-15 2017-10-10 上海现代哈森（商丘）药业有限公司 一种氢溴酸依立曲坦合成方法
JP2019502761A (ja) * 2016-01-21 2019-01-31 ラボラトリオス レヴィ エセエレ （（ｒ）−３−［（−１−メチルピロリジン−２−イル）メチル］−５−（２−フェニルスルホニルエチル）−１ｈ−インドールを作製する方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
CN1290697A (zh) * 1999-10-01 2001-04-11 辉瑞大药厂 酰化作用方法
CN1487932A (zh) * 2000-12-20 2004-04-07 新方法
CN1823060A (zh) * 2003-07-23 2006-08-23 辉瑞大药厂 制备α－多晶型氢溴酸依来曲普坦的改良方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL170330B1 (pl) 1990-10-15 1996-11-29 Pfizer Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US20030166704A1 (en) 2000-12-20 2003-09-04 Pfizer Inc. New process
JP2006522790A (ja) 2003-04-11 2006-10-05 ファイザー・インク エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物
US6927296B2 (en) * 2003-07-23 2005-08-09 Pfizer Inc. Process
EP2093224A1 (en) 2007-05-01 2009-08-26 Plus Chemicals B.V. Process for preparing eletriptan hydrobromide form beta
US20080319205A1 (en) * 2007-05-29 2008-12-25 Roman Bednar Process for preparing 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole
WO2009077858A2 (en) 2007-12-17 2009-06-25 Actavis Group Ptc Ehf Novel hemioxalate salt of eletriptan
US20090299077A1 (en) 2008-05-22 2009-12-03 Vinod Kumar Kansal Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
CN1290697A (zh) * 1999-10-01 2001-04-11 辉瑞大药厂 酰化作用方法
CN1487932A (zh) * 2000-12-20 2004-04-07 新方法
CN1823060A (zh) * 2003-07-23 2006-08-23 辉瑞大药厂 制备α－多晶型氢溴酸依来曲普坦的改良方法

Also Published As

Publication number Publication date
JP2012524736A (ja) 2012-10-18
IT1393700B1 (it) 2012-05-08
CA2756234A1 (en) 2010-10-28
EP2421853A1 (en) 2012-02-29
JP5663559B2 (ja) 2015-02-04
US20110166364A1 (en) 2011-07-07
ES2432066T3 (es) 2013-11-29
EP2421853B1 (en) 2013-07-24
CA2756234C (en) 2017-01-03
CN102414198A (zh) 2012-04-11
WO2010121673A1 (en) 2010-10-28
ITMI20090678A1 (it) 2010-10-23
US8426612B2 (en) 2013-04-23

Similar Documents

Publication Publication Date Title
US9938239B2 (en) Method for preparing silodosin
JP6699979B2 (ja) シロドシンおよびその中間体の合成方法ならびに結晶フォーム
CN107922326A (zh) 阿普斯特的制备方法及其中间体
EA016759B1 (ru) Способ получения алмотриптана высокой чистоты
CN102414198B (zh) 3-{[(2r)-1-甲基吡咯烷-2-基]甲基}-5-[2-(苯基磺酰基)乙基]-1h-吲哚的合成
JP2002507222A (ja) ペルヒドロイソインドール置換体の製造方法
JP2011516519A (ja) アルガトロバン一水和物の多形体及びその合成方法
TW519537B (en) Process for the preparation of tricylic amino-alcohol derivatives
JPH09502991A (ja) Ｎ−メチル−３−（１−メチル−４−ピペリジニル）−１ｈ−インドール−５−エタンスルホンアミドの製造法
RU2320655C2 (ru) УЛУЧШЕННЫЙ СПОСОБ ПОЛУЧЕНИЯ α-ПОЛИМОРФНОГО БРОМГИДРАТА ЭЛЕТРИПТАНА
CN105693603A (zh) 改良的马来酸茚达特罗制备工艺
CN101056853B (zh) 异吲哚衍生物的制备方法
JP2005104874A (ja) 光学活性なα−アミノ−ε−カプロラクタムまたはその塩の製造方法および製造の中間体
JP2012524736A5 (https=)
JP2015038053A (ja) ４−（２−メチル−１−イミダゾリル）−２，２−フェニルブタンアミドの製造方法
CN101466673A (zh) 制备n-羟基-3-[4-[[[2-(2-甲基-1h-吲哚-3-基)乙基]氨基]甲基]苯基]-2e-2-丙烯酰胺的盐的方法
CN105820106B (zh) 爱维莫潘中间体的制备方法
JP4742484B2 (ja) ３−アミノアルカン酸エステルの製造方法
TW591025B (en) Production of the piperazine derivative
WO2007013098A1 (en) A process for the preparation of almotriptan
CN114105961A (zh) 一种ido1抑制剂(ly-3381916)制备方法
JP3144921B2 (ja) ベンジルエステル誘導体及びその製造方法
WO2005066124A1 (ja) ピロリジン誘導体の製造法
CN113906011A (zh) 用于制备btk抑制剂的方法和中间体
WO2018100565A1 (en) Process for the preparation of indoline compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant